HUSSMAN STRATEGIC ADVISORS, INC. – Neurocrine Biosciences, Inc. Transaction History
HUSSMAN STRATEGIC ADVISORS, INC. portfolio value:
$3.31M
portfolio value
HUSSMAN STRATEGIC ADVISORS, INC. quarter portfolio value change:
+8.96%
quarter
Neurocrine Biosciences, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | 273K | $106.21 | 31.2K | |
| Q2 2022 | share | 0.00% | 0 shares | 116K | $97.48 | 31.2K | |
| Q1 2022 | share | Increase | +200.00% | 20.8K shares | 2.03M | $93.75 | 31.2K |
| Q4 2021 | share | Decrease | -32.90% | -5.1K shares | -601K | $84.63 | 10.4K |
| Q3 2021 | share | 0.00% | 0 shares | -21K | $95.91 | 15.5K | |
| Q2 2021 | share | Increase | 0.00% | 15.5K shares | 1.50M | $97.32 | 15.5K |
| Q4 2020 | share | Decrease | -100.00% | -10K shares | -962K | $95.85 | 0 |
| Q3 2020 | share | 0.00% | 0 shares | -258K | $96.16 | 10K | |
| Q2 2020 | share | Decrease | -33.33% | -5K shares | -78K | $122 | 10K |
| Q1 2020 | share | Increase | 0.00% | 15K shares | 1.29M | $86.55 | 15K |
| Q2 2019 | share | Decrease | -100.00% | -10K shares | -881K | $84.43 | 0 |
| Q1 2019 | share | 0.00% | 0 shares | 167K | $88.1 | 10K | |
| Q4 2018 | share | Increase | 0.00% | 10K shares | 714K | $71.41 | 10K |